JPH03101672A - Preparation of 2,5-furandicarboxyaldehyde - Google Patents

Preparation of 2,5-furandicarboxyaldehyde

Info

Publication number
JPH03101672A
JPH03101672A JP23961489A JP23961489A JPH03101672A JP H03101672 A JPH03101672 A JP H03101672A JP 23961489 A JP23961489 A JP 23961489A JP 23961489 A JP23961489 A JP 23961489A JP H03101672 A JPH03101672 A JP H03101672A
Authority
JP
Japan
Prior art keywords
oxygen
formula
catalyst system
copper salt
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP23961489A
Other languages
Japanese (ja)
Inventor
Hiroshi Takada
高田 博史
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP23961489A priority Critical patent/JPH03101672A/en
Publication of JPH03101672A publication Critical patent/JPH03101672A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To simply prepare the subject compound useful as a monomer for polymers, a crosslinking agent, etc., in a high yield by oxidizing 5- hydroxymethyl-2-furancarboxyaldehyde, etc., with profitable oxygen in the pres ence of a specific catalyst system. CONSTITUTION:5-Hydroxymethyl-2-furancarboxyaldehyde or 2,5-bishydroxymethyl furan as a raw material is oxidized with oxygen or an oxygen-containing gas in the presence of a catalyst system comprising 2,2,6,6-tetramethylpiperidineoxyl of the formula (R is H, OH, 1-20C alkoxy or benzyl) and a monovalent copper salt at 0-50 deg.C to provide the objective compound. The molar ratio of the com pound of the formula to the monovalent copper salt in the catalyst system is preferably 1/0.2-10 and the compound of the formula is employed in a amount of 0.01-20mol% based on the raw material.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は下記式(n)で表される5−ヒドロキシメチル
−2−フランカルポキシアルデヒド(以下IMFと記す
)又は下記式(ml)で表されル2.5−ビスヒドロキ
シメチルフラン(以下BHMFと記す)を酸化し、下記
式(IV)で表される2,5一フランジカルボキシアル
デヒド(以下FDAと記す)を製造する方法に関する。
Detailed Description of the Invention [Industrial Application Field] The present invention relates to 5-hydroxymethyl-2-furancarpoxyaldehyde (hereinafter referred to as IMF) represented by the following formula (n) or the following formula (ml). The present invention relates to a method for producing 2,5-furandicarboxyaldehyde (hereinafter referred to as FDA) represented by the following formula (IV) by oxidizing 2,5-bishydroxymethylfuran (hereinafter referred to as BHMF).

(I[r) FDAは高分子モノマー、架橋剤等として注目されてい
る。
(I[r) FDA is attracting attention as a polymer monomer, crosslinking agent, etc.

〔従来の技術及び発明が解決しようとする課題〕FDA
の製法として、従来、いろいろな方法が提案されている
[Prior art and problems to be solved by the invention] FDA
Conventionally, various methods have been proposed for the production of .

例えば、IMFの酸化反応によりFDAを得る方法とし
ては、無水クロム酸錯体を用いる方法(特開昭54 −
 9260号公報)、窒素酸化物を用いる方法(特開昭
55 − 49368号公報)、二酸化マンガンを用い
る方法(ソ連特許第282331号明細書)などが知ら
れている。また、5−クロロメチル−2−フルフラール
よりFDAを得る方法として、ヘキサメチレンテトラミ
ンと反応させ、生威した4級塩を加水分解する方法(東
独特許第26542号明細書)なども知られている。し
かしながら、これらの方法は反応試薬が比較的高価であ
り、かつ、原料に対して化学量論量必要であるため、経
済的な見地からははなはだ問題の多い方法である。また
、反応試薬の安全性、廃棄処理方法なども問題となるも
のが多い。
For example, as a method for obtaining FDA by the oxidation reaction of IMF, there is a method using a chromic anhydride complex (Japanese Unexamined Patent Application Publication No. 54-119)
9260), a method using nitrogen oxides (JP-A-55-49368), and a method using manganese dioxide (USSR Patent No. 282331). Furthermore, as a method for obtaining FDA from 5-chloromethyl-2-furfural, a method is known in which the resulting quaternary salt is hydrolyzed by reaction with hexamethylenetetramine (East German Patent No. 26542). . However, these methods are very problematic from an economic standpoint because the reaction reagents are relatively expensive and are required in stoichiometric amounts relative to the raw materials. In addition, there are many problems such as the safety of reaction reagents and disposal methods.

〔課題を解決するための手段〕[Means to solve the problem]

本発明者はかかる問題点を解決するために鋭意検討を重
ねた結果、HMF又はBHMFを酸化反応するにあたり
、特定の触媒系の存在下に、経済的に有利な酸素又は酸
素含有ガスを用いて酸化したところ、簡便で収率良くか
つ経済的に有利にFD′Aが得られることを見出し、本
発明を完或するに到った. 即ち本発明は、IMF又はBHMPを、下記式(I)で
表される2,2.6.6−−テトラメチルピペリジンオ
キシル及び1価の銅塩よりなる触媒系の存在下に、酸素
又は酸素含有ガスを用いて酸化することを特徴とするF
DAの製法を提供するものである。
As a result of intensive studies to solve these problems, the present inventors have discovered that in oxidizing HMF or BHMF, an economically advantageous oxygen or oxygen-containing gas is used in the presence of a specific catalyst system. Upon oxidation, it was discovered that FD'A could be obtained easily, in good yield, and economically, and the present invention was completed. That is, the present invention provides IMF or BHMP with oxygen or oxygen in the presence of a catalyst system consisting of 2,2.6.6-tetramethylpiperidineoxyl represented by the following formula (I) and a monovalent copper salt. F characterized by being oxidized using a containing gas
This provides a method for producing DA.

(式中RはH、OH、炭素数1〜20のアルコキシ基又
はペンジルオキシ基を表す.) 2.2.6.6−テトラメチルピペリジンオキシル類及
び1価の銅塩を触媒に用いて反応を行う方法に関しては
、アリルアルコール類についてはアルデヒドへの変換に
有効であることは知られているが{ジャーナル オブ 
アメリカン ケミカル ソサイアティ(Journal
 of AmericanChemical Soci
ety), 106. 3374(I984)) 、こ
の文献にはジオール類の酸化によりジアルデヒドを得る
方法については記載がなかった。また、ジオール類を化
学量論量の4−メトキシ−1−オキソー2.2.6.6
−テトラメチルビペリジニウム クロライドで酸化する
とラクトン及びアセタール類が生或することが報告され
ているが、ジアルデヒドの生或は報告されていなかった
{ジャーナル オブ オーガニック ケミストリー(J
ournal of Organic Chemist
ry)+  50+3930(I985) )。即ち、
FDAを収率良く製造するにあたり、安価な触媒をもっ
て行う方法については全く知られていなかった。
(In the formula, R represents H, OH, an alkoxy group having 1 to 20 carbon atoms, or a penzyloxy group.) 2.2.6.6-Tetramethylpiperidineoxyls and a monovalent copper salt are used as catalysts to carry out the reaction. Regarding the method of conversion, it is known that allyl alcohols are effective in converting them to aldehydes, but {Journal of
American Chemical Society (Journal)
of American Chemical Soci
ety), 106. 3374 (I984)), this document did not describe a method for obtaining dialdehydes by oxidizing diols. In addition, diols can be added in a stoichiometric amount of 4-methoxy-1-oxo2.2.6.6
- Tetramethylbiperidinium It has been reported that lactones and acetals are produced when oxidized with chloride, but the production of dialdehydes has not been reported {Journal of Organic Chemistry (J
our own organic chemist
ry)+50+3930(I985)). That is,
There was no known method for producing FDA with a high yield using an inexpensive catalyst.

しかしながら、本発明者らは、ジアルデヒドであるFD
Aを得るための出発原料となるHMF又はBHMFの酸
化反応を前記一般式{1)で表される2.2,6.6−
−テトラメチルピペリジンオキシルと1価の銅塩よりな
る触媒系存在下に、酸素又は酸素含有ガスにより酸化を
行ったところ、収率良< FDAが生威することを見出
し、本発明を完威したものである. 以下に本発明の詳細な内容を説明する.本発明において
、反応原料として用いられるIMF , BHMFは、
それぞれヘキソースの脱水反応、フルフリルアルコール
とホルマリンの反応により合威できる。また反応触媒に
用いる前記一般式(I)で表される2.2,6.6−テ
トラメチルピペリジンオキシルは、2.2,6.6−テ
トラメチルピペリジン又は4−ヒドロキシ−2.2.6
.6−テトラメチルピペリジンよりジャーナル オプオ
ーガニックケ業ストリー(Journa1 of Or
ga−nic Chemistry). 50. 13
34(I985)に記載の方法によって合戒できる。更
に反応触媒に用いる1価の銅塩としては特に塩化第一銅
が好ましい。
However, we found that the dialdehyde FD
The oxidation reaction of HMF or BHMF, which is the starting material for obtaining A, is carried out using the 2.2,6.6-
- When oxidation was carried out with oxygen or oxygen-containing gas in the presence of a catalyst system consisting of tetramethylpiperidineoxyl and a monovalent copper salt, it was discovered that FDA was produced in good yield, and the present invention was completed. It is something. The detailed content of the present invention will be explained below. In the present invention, IMF and BHMF used as reaction raw materials are:
They can be combined by the dehydration reaction of hexose and the reaction of furfuryl alcohol and formalin, respectively. 2.2,6.6-tetramethylpiperidineoxyl represented by the general formula (I) used as a reaction catalyst is 2.2,6.6-tetramethylpiperidine or 4-hydroxy-2.2.6
.. 6-Tetramethylpiperidine from Journal 1 of Or
ga-nic chemistry). 50. 13
34 (I985). Further, as the monovalent copper salt used as a reaction catalyst, cuprous chloride is particularly preferable.

前記一般式(I)で表される2.2.6.6−テトラメ
チルピペリジンオキシルと1価の銅塩の量比としては1
 /0.2〜10のモル比で使用することが望ましい,
 2.2.6.6−テトラメチルピペリジンオキシルは
原料に対して0.01〜20モル%使用することが望ま
しい。
The quantitative ratio of 2.2.6.6-tetramethylpiperidineoxyl represented by the general formula (I) and the monovalent copper salt is 1.
It is desirable to use it at a molar ratio of /0.2 to 10.
2.2.6.6-Tetramethylpiperidineoxyl is preferably used in an amount of 0.01 to 20 mol% based on the raw materials.

本発明の酸化反応に用いられる溶媒としては、有機溶媒
であれば特に制限は無いが、N.N−ジメチルホルムア
ミド、ジメチルスルホキシド、N,N−ジメチルアセト
アミド、1−メチル−2ビロリドンなどの非プロトン性
極性溶媒が特に有効である。
The solvent used in the oxidation reaction of the present invention is not particularly limited as long as it is an organic solvent. Aprotic polar solvents such as N-dimethylformamide, dimethylsulfoxide, N,N-dimethylacetamide, and 1-methyl-2-pyrrolidone are particularly effective.

本発明において、酸素又は酸素含有ガスの導入法は特に
制限はないが、反応原料と触媒を含む溶媒中に導入する
ことが望ましい。
In the present invention, the method of introducing oxygen or oxygen-containing gas is not particularly limited, but it is desirable to introduce it into a solvent containing reaction raw materials and a catalyst.

本発明の反応温度はO〜50゜Cの範囲が好適な範囲と
して選ばれる。この温度より高くても低くても収率が低
下する。反応時間は反応条件により適宜選択されるが通
常0.5〜10時間である.〔発明の効果〕 本発明は、高分子七ノマー、架橋剤等として注目される
FDAについて、IMF又はBHMFより製造するにあ
たり、前記一般式(I)で表される2,2,6.6−テ
トラメチルピペリジンオキシル及び1価の銅塩を触媒に
用い、経済的に有利な酸素又は酸素含有ガスにて反応さ
せることにより、簡便で収率良くかつ経済的に有利に2
.5−フランジカルボキシアルデヒド(FDA)を製造
する方法を提供することができる。
The reaction temperature of the present invention is preferably selected from a range of 0 to 50°C. The yield decreases whether the temperature is higher or lower than this temperature. The reaction time is appropriately selected depending on the reaction conditions, but is usually 0.5 to 10 hours. [Effects of the Invention] The present invention provides 2,2,6.6- represented by the general formula (I) when producing FDA from IMF or BHMF, which is attracting attention as a polymer heptanomer, a crosslinking agent, etc. By using tetramethylpiperidine oxyl and a monovalent copper salt as a catalyst and reacting in economically advantageous oxygen or oxygen-containing gas, 2 can be easily and economically advantageously produced with good yield.
.. A method of producing 5-furandicarboxaldehyde (FDA) can be provided.

〔実施例〕〔Example〕

以下、実施例にて本発明を更に詳細に説明するが、本発
明はこれらの実施例に限定されるものではない。
EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.

実施例1 100s7の4つロフラスコに、5−ヒドロキシメチル
−2−フラン力ルボキシアルデヒド(IIMF)1.2
6gr (I0ma+ol) 、4−メトキシ−2.2
,6.6 −テトラメチルピペリジンオキシル0.18
6 gr ( 1lIIIlo■)、塩化第一銅0.9
9gr (I+++mol)、及びジメチルホルムアミ
ド25−を入れ、20゜Cにて撹拌下酸素を50WL!
/sinの速度でフラスコの底の部分より導入した。5
時間後、酸素導入を停止し、約30一のクロロホルム及
び約20grのIN塩酸水溶液を加えて、分層した。ク
ロロホルム層をよく水洗し、pHを中性とし硫酸マグネ
シウムで乾燥したのち、クロロホルムを減圧下に留去し
た。
Example 1 1.2 5-hydroxymethyl-2-furanic carboxyaldehyde (IIMF) was added to a 100s7 four-bottle flask.
6gr (I0ma+ol), 4-methoxy-2.2
,6.6-tetramethylpiperidineoxyl0.18
6 gr (1lIIIlo■), cuprous chloride 0.9
Add 9gr (I+++mol) and 25-dimethylformamide, and add 50WL of oxygen while stirring at 20°C!
The solution was introduced from the bottom of the flask at a rate of /sin. 5
After an hour, the introduction of oxygen was stopped, and about 30 grams of chloroform and about 20 grams of IN hydrochloric acid aqueous solution were added to separate the layers. The chloroform layer was thoroughly washed with water, the pH was made neutral, and the layer was dried over magnesium sulfate, and then the chloroform was distilled off under reduced pressure.

得られた褐色の残留物は0.95grであり、2.5−
フランジカルボキシアルデヒドの純度は72%であった
(収率55%)。得られた残留物をクロロホルムで再結
晶したところ融点110℃であり、NMRによりFD^
であることを確認した。
The brown residue obtained was 0.95 gr, 2.5-
The purity of furandicarboxaldehyde was 72% (yield 55%). When the obtained residue was recrystallized from chloroform, it had a melting point of 110°C, and it was found to be FD^ by NMR.
It was confirmed that

NMR(}容媒CDCh):  δ7.4(s),  
69.9(s)実施例2 実施例1において溶媒として用いたジメチルホルムアミ
ドの代わりにジメチルスルホキシドを用いた以外は実施
例lと同様に行った結果、FDAの収率は62%であっ
た。
NMR (}vessel CDCh): δ7.4(s),
69.9(s) Example 2 The same procedure as in Example 1 was performed except that dimethyl sulfoxide was used instead of dimethylformamide used as the solvent in Example 1, and the yield of FDA was 62%.

実施例3 実施例2において、5−ヒドロキシメチル−2−フラン
カルボキシアルデヒド(IMF) 1.26gr(I0
mmol)の代わりに2.5−ビスヒドロキシメチルフ
ラン(BHMP) 1.28gr(I0mmol)を用
いた以外は実施例2と同様に行った結果、FDAの収率
は56%であった。
Example 3 In Example 2, 1.26 gr of 5-hydroxymethyl-2-furancarboxaldehyde (IMF) (IO
Example 2 was repeated except that 1.28 gr (10 mmol) of 2.5-bishydroxymethylfuran (BHMP) was used instead of 2.5-bishydroxymethylfuran (BHMP), and the yield of FDA was 56%.

Claims (1)

【特許請求の範囲】  5−ヒドロキシメチル−2−フランカルボキシアルデ
ヒド又は2,5−ビスヒドロキシメチルフランを、下記
式( I )で表される2,2,6,6−テトラメチルピ
ペリジンオキシル及び1価の銅塩よりなる触媒系の存在
下に、酸素又は酸素含有ガスを用いて酸化することを特
徴とする2,5−フランジカルボキシアルデヒドの製法
。 ▲数式、化学式、表等があります▼・・・( I ) (式中RはH、OH、炭素数1〜20のアルコキシ基又
はベンジルオキシ基を表す。)
[Scope of Claims] 5-hydroxymethyl-2-furancarboxaldehyde or 2,5-bishydroxymethylfuran is combined with 2,2,6,6-tetramethylpiperidineoxyl represented by the following formula (I) and 1 1. A method for producing 2,5-furandicarboxaldehyde, which comprises oxidizing it using oxygen or an oxygen-containing gas in the presence of a catalyst system consisting of a copper salt having a hydric acid. ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(I) (In the formula, R represents H, OH, an alkoxy group having 1 to 20 carbon atoms, or a benzyloxy group.)
JP23961489A 1989-09-14 1989-09-14 Preparation of 2,5-furandicarboxyaldehyde Pending JPH03101672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23961489A JPH03101672A (en) 1989-09-14 1989-09-14 Preparation of 2,5-furandicarboxyaldehyde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23961489A JPH03101672A (en) 1989-09-14 1989-09-14 Preparation of 2,5-furandicarboxyaldehyde

Publications (1)

Publication Number Publication Date
JPH03101672A true JPH03101672A (en) 1991-04-26

Family

ID=17047358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23961489A Pending JPH03101672A (en) 1989-09-14 1989-09-14 Preparation of 2,5-furandicarboxyaldehyde

Country Status (1)

Country Link
JP (1) JPH03101672A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072732A2 (en) * 2000-03-27 2001-10-04 E.I. Dupont De Nemours And Company Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan
US7432382B2 (en) * 2004-12-10 2008-10-07 Archer-Daniels-Midland Company Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
US7700788B2 (en) 2006-10-31 2010-04-20 Battelle Memorial Institute Hydroxymethyl furfural oxidation methods
WO2012004069A1 (en) * 2010-07-06 2012-01-12 Evonik Degussa Gmbh Process for producing 2,5-diformylfuran and derivatives thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072732A2 (en) * 2000-03-27 2001-10-04 E.I. Dupont De Nemours And Company Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan
WO2001072732A3 (en) * 2000-03-27 2002-07-25 Du Pont Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan
US7432382B2 (en) * 2004-12-10 2008-10-07 Archer-Daniels-Midland Company Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
US7579490B2 (en) 2004-12-10 2009-08-25 Archer-Daniels-Midland Company Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
US7700788B2 (en) 2006-10-31 2010-04-20 Battelle Memorial Institute Hydroxymethyl furfural oxidation methods
US8193381B2 (en) 2006-10-31 2012-06-05 Battelle Memorial Institute Hydroxymethyl furfural oxidation methods
US8193382B2 (en) 2006-10-31 2012-06-05 Battelle Memorial Institute Hydroxymethyl furfural oxidation methods
WO2012004069A1 (en) * 2010-07-06 2012-01-12 Evonik Degussa Gmbh Process for producing 2,5-diformylfuran and derivatives thereof
DE102010030991A1 (en) * 2010-07-06 2012-01-12 Evonik Degussa Gmbh Process for the preparation of 2,5-diformylfuran and its derivatives

Similar Documents

Publication Publication Date Title
KR101936966B1 (en) Process for the synthesis of 2,5-furandicarboxylic acid
KR20150063059A (en) Method for synthesising 2,5-furandicarboxylic acid from a composition containing furan-2,5-dialdehyde
KR101715169B1 (en) Method for preparing 2,5-furandicarboxylic acid
KR20140106579A (en) Improved method for selectively oxidizing 5-hydroxymethyl furaldehyde
CN114605362A (en) Preparation method of 2, 5-furandicarboxylic acid
JPH0579055B2 (en)
JPH03101672A (en) Preparation of 2,5-furandicarboxyaldehyde
Zhu et al. A green process for the oxidative lactonization of 1, 2-benzenedimethanol by tungstic acid with aqueous H 2 O 2
JP4788022B2 (en) Process for producing aromatic polycarboxylic acid
JPS6024781B2 (en) Method for producing cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid
CN108144612B (en) Cobalt-based catalyst for synthesizing carboxylic ester by one-pot method and preparation and application thereof
CN113318730A (en) Delta-MnO 2 catalyst and preparation method and application thereof
JPS63130556A (en) Production of pyromellitic acid
JP2950948B2 (en) Method for producing 3-methylquinoline-8-carboxylic acid
TWI542583B (en) Oxidation process
CN113651684B (en) Preparation method of 4-hydroxy-2-butynoic acid
JP7278315B2 (en) Method for producing 5-alkoxymethylfurfural
JP7384049B2 (en) Method for producing carbonyl compounds
CN115819369B (en) Preparation process of intermediate 4-methylthiazole
EP0635468B1 (en) Method of obtaining alpha-substituted omega-hydroperfluoroalkanes
CN112521397B (en) Preparation method of 2, 6-dioxabicyclo- (3.3.0) -octane-3, 7-dione
JP5000031B2 (en) Method for producing aromatic-o-dialdehyde compound
JP4678081B2 (en) Method for producing trimellitic acid
JP2019142842A (en) Method for producing carbonyl compound
US3256325A (en) Process for the production of alpha-chloroglutaric acid